ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
58 hedge funds and large institutions have $21.6M invested in Zynerba Pharmaceuticals, Inc in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Holders
58
Holding in Top 10
–
Calls
$1.63M
Puts
$1.29M
Top Buyers
| 1 | +$3.51M | |
| 2 | +$976K | |
| 3 | +$921K | |
| 4 |
Renaissance Technologies
New York
|
+$476K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$451K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$374K | |
| 3 | -$171K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$154K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$127K |